Identification and validation of miR-583 and mir-877-5p as biomarkers in patients with breast cancer: an integrated experimental and bioinformatics research

Abstract Objectives Breast cancer (BC) is one of the most common cancers with a high mortality rate in women worldwide. The advantages of early cancer diagnosis are apparent, and it is a critical factor in increasing the patient’s life and survival. According to mounting evidence, microRNAs (miRNAs)...

Full description

Bibliographic Details
Main Authors: Zahra Foruzandeh, Mohammad Reza Alivand, Mehdi Ghiami-Rad, Mohammad Zaefizadeh, Saeid Ghorbian
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Research Notes
Subjects:
Online Access:https://doi.org/10.1186/s13104-023-06343-w
_version_ 1797827692164284416
author Zahra Foruzandeh
Mohammad Reza Alivand
Mehdi Ghiami-Rad
Mohammad Zaefizadeh
Saeid Ghorbian
author_facet Zahra Foruzandeh
Mohammad Reza Alivand
Mehdi Ghiami-Rad
Mohammad Zaefizadeh
Saeid Ghorbian
author_sort Zahra Foruzandeh
collection DOAJ
description Abstract Objectives Breast cancer (BC) is one of the most common cancers with a high mortality rate in women worldwide. The advantages of early cancer diagnosis are apparent, and it is a critical factor in increasing the patient’s life and survival. According to mounting evidence, microRNAs (miRNAs) may be crucial regulators of critical biological processes. miRNA dysregulation has been linked to the beginning and progression of various human malignancies, including BC, and can operate as tumor suppressors or oncomiRs. This study aimed to identify novel miRNA biomarkers in BC tissues and non-tumor adjacent tissues of patients with BC. Microarray datasets GSE15852 and GSE42568 for differentially expressed genes (DEGs) and GSE45666, GSE57897, and GSE40525 for differentially expressed miRNAs (DEMs) retrieved from the Gene Expression Omnibus (GEO) database were analyzed using “R” software. A protein-protein interaction (PPI) network was created to identify the hub genes. MirNet, miRTarBase, and MirPathDB databases were used to predict DEMs targeted genes. Functional enrichment analysis was used to demonstrate the topmost classifications of molecular pathways. The prognostic capability of selected DEMs was evaluated through a Kaplan-Meier plot. Moreover, the specificity and sensitivity of detected miRNAs to discriminate BC from adjacent controls were assessed by area under the curve (AUC) using the ROC curve analysis. In the last phase of this study, gene expression on 100 BC tissues and 100 healthy adjacent tissues were analyzed and calculated by using the Real-Time PCR method. Results This study declared that miR-583 and miR-877-5p were downregulated in tumor samples in comparison to adjacent non-tumor samples (|logFC|< 0 and P ≤ 0.05). Accordingly, ROC curve analysis demonstrated the biomarker potential of miR-877-5p (AUC = 0.63) and miR-583 (AUC = 0.69). Our results showed that has-miR-583 and has-miR-877-5p could be potential biomarkers in BC.
first_indexed 2024-04-09T12:52:25Z
format Article
id doaj.art-2085cda2bef34293b8e32cde70ff7c14
institution Directory Open Access Journal
issn 1756-0500
language English
last_indexed 2024-04-09T12:52:25Z
publishDate 2023-05-01
publisher BMC
record_format Article
series BMC Research Notes
spelling doaj.art-2085cda2bef34293b8e32cde70ff7c142023-05-14T11:07:19ZengBMCBMC Research Notes1756-05002023-05-0116111210.1186/s13104-023-06343-wIdentification and validation of miR-583 and mir-877-5p as biomarkers in patients with breast cancer: an integrated experimental and bioinformatics researchZahra Foruzandeh0Mohammad Reza Alivand1Mehdi Ghiami-Rad2Mohammad Zaefizadeh3Saeid Ghorbian4Department of Molecular Genetics, Ahar Branch, Islamic Azad UniversityEye Research Center, The Five Senses Health Institute, Rassoul Akram Hospital, Iran University of Medical SciencesDepartment of Microbiology, Faculty of Basic Sciences, Ahar Branch, Islamic Azad UniversityArdabil Branch, Islamic Azad UniversityDepartment of Molecular Genetics, Ahar Branch, Islamic Azad UniversityAbstract Objectives Breast cancer (BC) is one of the most common cancers with a high mortality rate in women worldwide. The advantages of early cancer diagnosis are apparent, and it is a critical factor in increasing the patient’s life and survival. According to mounting evidence, microRNAs (miRNAs) may be crucial regulators of critical biological processes. miRNA dysregulation has been linked to the beginning and progression of various human malignancies, including BC, and can operate as tumor suppressors or oncomiRs. This study aimed to identify novel miRNA biomarkers in BC tissues and non-tumor adjacent tissues of patients with BC. Microarray datasets GSE15852 and GSE42568 for differentially expressed genes (DEGs) and GSE45666, GSE57897, and GSE40525 for differentially expressed miRNAs (DEMs) retrieved from the Gene Expression Omnibus (GEO) database were analyzed using “R” software. A protein-protein interaction (PPI) network was created to identify the hub genes. MirNet, miRTarBase, and MirPathDB databases were used to predict DEMs targeted genes. Functional enrichment analysis was used to demonstrate the topmost classifications of molecular pathways. The prognostic capability of selected DEMs was evaluated through a Kaplan-Meier plot. Moreover, the specificity and sensitivity of detected miRNAs to discriminate BC from adjacent controls were assessed by area under the curve (AUC) using the ROC curve analysis. In the last phase of this study, gene expression on 100 BC tissues and 100 healthy adjacent tissues were analyzed and calculated by using the Real-Time PCR method. Results This study declared that miR-583 and miR-877-5p were downregulated in tumor samples in comparison to adjacent non-tumor samples (|logFC|< 0 and P ≤ 0.05). Accordingly, ROC curve analysis demonstrated the biomarker potential of miR-877-5p (AUC = 0.63) and miR-583 (AUC = 0.69). Our results showed that has-miR-583 and has-miR-877-5p could be potential biomarkers in BC.https://doi.org/10.1186/s13104-023-06343-wMicroRNAmiR-583BiomarkerBreast cancermiR-877-5p
spellingShingle Zahra Foruzandeh
Mohammad Reza Alivand
Mehdi Ghiami-Rad
Mohammad Zaefizadeh
Saeid Ghorbian
Identification and validation of miR-583 and mir-877-5p as biomarkers in patients with breast cancer: an integrated experimental and bioinformatics research
BMC Research Notes
MicroRNA
miR-583
Biomarker
Breast cancer
miR-877-5p
title Identification and validation of miR-583 and mir-877-5p as biomarkers in patients with breast cancer: an integrated experimental and bioinformatics research
title_full Identification and validation of miR-583 and mir-877-5p as biomarkers in patients with breast cancer: an integrated experimental and bioinformatics research
title_fullStr Identification and validation of miR-583 and mir-877-5p as biomarkers in patients with breast cancer: an integrated experimental and bioinformatics research
title_full_unstemmed Identification and validation of miR-583 and mir-877-5p as biomarkers in patients with breast cancer: an integrated experimental and bioinformatics research
title_short Identification and validation of miR-583 and mir-877-5p as biomarkers in patients with breast cancer: an integrated experimental and bioinformatics research
title_sort identification and validation of mir 583 and mir 877 5p as biomarkers in patients with breast cancer an integrated experimental and bioinformatics research
topic MicroRNA
miR-583
Biomarker
Breast cancer
miR-877-5p
url https://doi.org/10.1186/s13104-023-06343-w
work_keys_str_mv AT zahraforuzandeh identificationandvalidationofmir583andmir8775pasbiomarkersinpatientswithbreastcanceranintegratedexperimentalandbioinformaticsresearch
AT mohammadrezaalivand identificationandvalidationofmir583andmir8775pasbiomarkersinpatientswithbreastcanceranintegratedexperimentalandbioinformaticsresearch
AT mehdighiamirad identificationandvalidationofmir583andmir8775pasbiomarkersinpatientswithbreastcanceranintegratedexperimentalandbioinformaticsresearch
AT mohammadzaefizadeh identificationandvalidationofmir583andmir8775pasbiomarkersinpatientswithbreastcanceranintegratedexperimentalandbioinformaticsresearch
AT saeidghorbian identificationandvalidationofmir583andmir8775pasbiomarkersinpatientswithbreastcanceranintegratedexperimentalandbioinformaticsresearch